Condition
    Effectiveness 2/5

    Curcumin for Endometriosis

    Curcumin shows consistent anti-inflammatory activity in endometriosis models and small human pilot work, but no adequately powered trial has demonstrated reduced pelvic pain or lesion burden.

    Overview

    Curcumin shows consistent anti-inflammatory activity in endometriosis models and small human pilot work, but no adequately powered trial has demonstrated reduced pelvic pain or lesion burden.

    Verdict

    Mixed evidence

    Consistent anti-inflammatory activity in endometriosis models and small human pilot work, but no adequately powered trial has shown reduced pain or lesion burden.

    How It Works

    Curcumin inhibits NF-kB signalling, reduces inflammatory prostaglandins and cytokines, and in laboratory models reduces endometriotic cell proliferation and angiogenesis.

    Dosing & Protocol

    Typical dose

    Recommended dose
    500-1000 mg curcumin with a bioavailability enhancer, if trialled
    Expected timeframe
    2-3 months to assess any symptomatic effect

    Protocol

    notes
    Take with fat-containing food; standard turmeric powder contains only around 3% curcumin
    dosage
    500-1000 mg curcumin daily with a bioavailability enhancer (piperine or phytosome form)
    duration
    2-3 months to assess any symptomatic effect

    Evidence

    What the studies say

    Cell and animal studies of curcumin in endometriosis are consistently positive, showing reduced lesion growth and inflammatory markers. Human evidence is limited to small pilot studies without adequate controls or power. The mechanistic rationale is genuinely plausible — the inflammatory pathways targeted are the ones driving the disease — but no properly sized trial has confirmed clinical benefit, and bioavailability remains a practical limitation.

    No studies are yet linked to both Curcumin and Endometriosis.

    Safety

    Caveats

    {"No adequately powered human trial exists","Poor absorption without formulation enhancement","May interact with blood thinners and affect iron absorption"}

    Less likely to help if

    Women with severe structural disease — adhesions, large endometriomas — should not expect an anti-inflammatory supplement to address mechanical pain sources.

    Medical Disclaimer

    The information provided on this website is for educational and informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or before starting any supplement regimen.

    Individual results may vary. The statements on this website have not been evaluated by the Food and Drug Administration. Products and information are not intended to diagnose, treat, cure, or prevent any disease.